David W. Pritchard
2013
In 2013, David W. Pritchard earned a total compensation of $1.2M as President & Chief Executive Officer at KaloBios Pharmaceuticals, a 225% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $251,625 |
|---|---|
| Option Awards | $485,175 |
| Salary | $417,500 |
| Other | $892 |
| Total | $1,155,192 |
Pritchard received $485.2K in option awards, accounting for 42% of the total pay in 2013.
Pritchard also received $251.6K in non-equity incentive plan, $417.5K in salary and $892 in other compensation.
Rankings
In 2013, David W. Pritchard's compensation ranked 5,991st out of 12,286 executives tracked by ExecPay. In other words, Pritchard earned more than 51.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,991 out of 12,286 | 51st |
Division Manufacturing | 2,079 out of 4,612 | 55th |
Major group Chemicals And Allied Products | 608 out of 1,462 | 58th |
Industry group Drugs | 438 out of 1,156 | 62nd |
Industry Pharmaceutical Preparations | 352 out of 890 | 60th |
Source: SEC filing on April 29, 2014.
Pritchard's colleagues
We found two more compensation records of executives who worked with David W. Pritchard at KaloBios Pharmaceuticals in 2013.